Microbot Medical logo

Microbot Medical

NASDAQ:MBOTLive AI agent

Investor website: https://microbotmedical.com/

About

Microbot Medical is dedicated to delivering transformative interventional robotic solutions that prioritize patient care, empower healthcare providers, and enable access to advanced care anytime and anywhere. The company is pioneering a new category of surgical robotics with its LIBERTY Endovascular Robotic System, which aims to redefine medical technology's role in empowering healthcare professionals and enhancing accessibility for all stakeholders. The mission is driven by a patient-first mindset, collaboration, and a sense of responsibility to those they serve.

Verified company data

Shares outstanding
45,545,939
Fully diluted shares
81,846,616
Projects

LIBERTY® Endovascular Robotic System

Performance Meets Precision

Step into the next generation of endovascular intervention. LIBERTY® is engineered for physicians who demand control, efficiency and peace of mind.

Test Drive LIBERTY™

Robotic Drive

Remote Control

Mounting Arm

Drive the Future of Intervention™

LIBERTY® delivers smooth, responsive peripheral endovascular navigation in a single-use, remotely operated design that fits seamlessly into your workflow. You are in command, even from across the room.

Test Drive LIBERTY™

A New Era in Endovascular Care

Unlike traditional manual techniques, LIBERTY Endovascular Robotic System offers a single-use, compact solution that enables controlled remote operation while transforming vascular access and navigation without the complexity or cost of capital equipment.

No Large Capital Investment

Single-use without need for capital investment.

Reduce Radiation Exposure

92% reduction in radiation exposure.1,2

Compact Design

Compact system integrates effortlessly into your existing workflow.

Control and Comfort

Remote, seated operation enables improved ergonomics.

Efficient Set-Up

Simple and intuitive setup in under 5 minutes.¹

Universal Compatibility

Compatible with your preferred guidewires and catheters.

AccuGrip™

AccuGrip™ securely holds wires and catheters

Download LIBERTY® Brochure

Intended Use and Indications for Use:

The LIBERTY Endovascular Robotic System is intended for use in the remote delivery and manipulation of guidewires and catheters, and remote manipulation of guide catheters to facilitate navigation to anatomical targets in the peripheral vasculature.

The LIBERTY Endovascular Robotic System is not intended for coronary or neurointerventional procedures.

1Abstract No. LBA15 Remote-Controlled Endovascular Navigation with a Miniature, Single-Use, Robotic System. Results of the ACCESS-PVI Trial Cornelis, F. et al. Journal of Vascular and Interventional Radiology, Volume 36, Issue 3, S235 – S236

2Data on file

3Research report from wet-lab with nine experienced interventional radiologists. Set-up times and learning curve will vary with user​

*Within the product specifications

LIBERTY was designed to address the growing unmet needs in healthcare impacting physicians, hospitals, and patients.

Radiation & Ergonomic Risks1

Interventionalists have:

6× higher risk of cataracts
3× higher risk of malignancy

Ergonomic / Musculoskeletal Risks:

66% reported musculoskeletal pain related to wearing lead protective equipment
60% reported at least one orthopedic injury

Staff Shortage

IR is ranked 2nd in specialties facing the greatest physician shortages2
Healthcare faces staff shortages of 85K+ by 20363
Nearly 50% of physicians report burnout3
1 in 5 physicians report experiencing depression, exacerbating workforce gaps3

Access to Quality Care4

20% of Americans live in rural areas where only 10% of doctors practice
80% of rural Americans are medically underserved
~200 rural hospitals have closed since 2005

Family Planning5

28% of women respondents reported being discouraged from working in the Cath lab due to pregnancy or considering pregnancy.
71% of women respondents said they wanted the option to step away from the Cath lab during pregnancy.

Sources

1 https://evtoday.com/articles/2025-early-career-insights-2/radiation-safety-dont-wait-until-its-too-late?utm_source=linkedin&utm_medium=newsletter&utm_campaign=etDE1125_Gore

2 https://axuall.com/wp-content/uploads/2025/06/Axuall_-2025-Clinician-Workforce-Insights-Report-final.pdf

3 https://nihcm.org/newsletter/rising-healthcare-workforce-shortage​

4 https://nihcm.org/publications/rural-health-needs-in-america-challenges-and-solutions

5 https://pmc.ncbi.nlm.nih.gov/articles/PMC12038281/​

Leadership

Harel Gadot (CEO, President and Chairman), Simon Sharon (GM, Chief Technology Officer), Rachel Vaknin (Chief Financial Officer), Juan Diaz-Cartelle, MD (Chief Medical Officer), Earl Adamy (VP, Strategic Marketing & Business Development), Christina Bailey (VP, Sales), Eran Cohen (VP, Global Integration), Naama Moav (VP, Human Resources), Noa Ofer, PhD (VP, Quality Assurance and Regulatory Affairs), Allison Rosefort (VP, Marketing), Alon Tamir (VP, Sales, EMEA), Martin J. Madden (Director), Scott Burell (Director), Aileen Stockburger (Director), P. Laxminarain (Director), Tal Wenderow (Director), David Wilson (Director)

Verified data last updated:

Recent filings

Investor FAQ

Answers last refreshed: